Home » Stocks » ICPT

Intercept Pharmaceuticals, Inc. (ICPT)

Stock Price: $29.46 USD 1.38 (4.91%)
Updated Jan 22, 2021 4:00 PM EST - Market closed
After-hours: $29.73 +0.27 (0.92%) Jan 22, 6:42 PM
Market Cap 907.62M
Revenue (ttm) 300.92M
Net Income (ttm) -320.89M
Shares Out 32.99M
EPS (ttm) -9.75
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 22
Last Price $29.46
Previous Close $28.08
Change ($) 1.38
Change (%) 4.91%
Day's Open 27.99
Day's Range 27.33 - 29.55
Day's Volume 892,131
52-Week Range 24.48 - 98.33

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
The Motley Fool - 6 hours ago

These bounce-back plays might be diamonds in the rough.

Other stocks mentioned: KGC, VLNCF
GlobeNewsWire - 1 week ago

NEW YORK, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to...

Seeking Alpha - 2 weeks ago

Intercept has suffered an important set back with the FDA's CRL for Ocaliva in NASH with liver fibrosis. Ocaliva may still be approvable in NASH and the risk-reward for ICPT is more appealing ...

Newsfile Corp - 2 weeks ago

New York, New York--(Newsfile Corp. - January 4, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securi...

Newsfile Corp - 2 weeks ago

New York, New York--(Newsfile Corp. - January 4, 2021) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. (NASDAQ: ICP...

PRNewsWire - 2 weeks ago

LOS ANGELES, Jan. 4, 2021 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Intercept Pharmaceuticals, ...

Accesswire - 2 weeks ago

NEW YORK, NY / ACCESSWIRE / January 3, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Sh...

Other stocks mentioned: BSX, NAK
Business Wire - 2 weeks ago

NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Intercept Pharmaceuticals, Inc. ("Intercept" or "the Company...

PRNewsWire - 2 weeks ago

NEW YORK, Jan. 2, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Intercept Pharmaceuticals, Inc. ("Intercept" or the "Company") (NASDAQ: ICPT) ...

Newsfile Corp - 2 weeks ago

New York, New York--(Newsfile Corp. - January 2, 2021) -  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. (NASDAQ: IC...

Business Wire - 3 weeks ago

NEW YORK--(BUSINESS WIRE)-- #ClassAction--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the ...

Business Wire - 3 weeks ago

LOS ANGELES--(BUSINESS WIRE)---- $ICPT #classaction--The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Intercept Pharmaceuticals, Inc. ...

The Motley Fool - 3 weeks ago

These companies are eager to say good riddance to the year that was.

Other stocks mentioned: AMRN, IVR, NGL, NXTC, PBF, SNDL, TCDA, TELL, WPG
Newsfile Corp - 3 weeks ago

New York, New York--(Newsfile Corp. - December 28, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secu...

Business Wire - 3 weeks ago

NEW YORK--(BUSINESS WIRE)-- #ClassAction--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the ...

Newsfile Corp - 3 weeks ago

New York, New York--(Newsfile Corp. - December 28, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. (NASDAQ: I...

Accesswire - 3 weeks ago

NEW YORK, NY / ACCESSWIRE / December 28, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you ...

Other stocks mentioned: BIIB, KNDI
GlobeNewsWire - 3 weeks ago

NEW YORK, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Intercept Pharmaceuticals, In...

Newsfile Corp - 3 weeks ago

New York, New York--(Newsfile Corp. - December 26, 2020) - Pomerantz LLP announces that a class action lawsuit has been filed against Intercept Pharmaceuticals, Inc. ("Intercept" or the "Compa...

Accesswire - 4 weeks ago

NEW YORK, NY / ACCESSWIRE / December 24, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. ...

Other stocks mentioned: BABA, TILE
GlobeNewsWire - 4 weeks ago

NEW YORK, Dec. 24, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) between Se...

Newsfile Corp - 4 weeks ago

New York, New York--(Newsfile Corp. - December 24, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Intercept Pharmaceuticals, Inc...

Newsfile Corp - 4 weeks ago

New York, New York--(Newsfile Corp. - December 23, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secu...

GlobeNewsWire - 4 weeks ago

NEW YORK, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) be...

Accesswire - 1 month ago

NEW YORK, NY / ACCESSWIRE / December 22, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost...

Other stocks mentioned: HPQ, RTX
PRNewsWire - 1 month ago

NEW YORK, Dec. 22, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) between Septem...

GlobeNewsWire - 1 month ago

Investors with losses are encouraged to contact the firm before January 4, 2021; click here to submit trade information

Newsfile Corp - 1 month ago

New York, New York--(Newsfile Corp. - December 21, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Intercept Pharmaceuticals, Inc...

GlobeNewsWire - 1 month ago

LOS ANGELES, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 4, 202 1 deadline to file a lead plaintiff motion in the class acti...

Newsfile Corp - 1 month ago

New York, New York--(Newsfile Corp. - December 15, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. (NASDAQ: I...

Newsfile Corp - 1 month ago

New York, New York--(Newsfile Corp. - December 15, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Intercept Pharmaceuticals, Inc...

Newsfile Corp - 1 month ago

New York, New York--(Newsfile Corp. - December 15, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secu...

GlobeNewsWire - 1 month ago

NEW YORK, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securiti...

Newsfile Corp - 1 month ago

New York, New York--(Newsfile Corp. - December 14, 2020) - Pomerantz LLP announces that a class action lawsuit has been filed against Intercept Pharmaceuticals, Inc. ("Intercept" or the "Compa...

GlobeNewsWire - 1 month ago

LOS ANGELES, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 4, 202 1 deadline to file a lead plaintiff motion in the class acti...

GlobeNewsWire - 1 month ago

NEW YORK, Dec. 12, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Intercept Pharmaceuticals, Inc.  (“Intercept” or the “Company”) (NASDAQ: ...

Newsfile Corp - 1 month ago

New York, New York--(Newsfile Corp. - December 10, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secu...

PRNewsWire - 1 month ago

NEW YORK, Dec. 10, 2020 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities c...

Newsfile Corp - 1 month ago

New York, New York--(Newsfile Corp. - December 10, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Intercept Pharmaceuticals, Inc...

GlobeNewsWire - 1 month ago

Jerry Durso Appointed CEO Effective January 1, 2021 ; Founder, President and CEO Mark Pruzansk i to Continue as Board Member and Advis o r

Newsfile Corp - 1 month ago

New York, New York--(Newsfile Corp. - December 9, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secur...

Newsfile Corp - 1 month ago

New York, New York--(Newsfile Corp. - December 9, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. (NASDAQ: IC...

Zacks Investment Research - 1 month ago

Intercept (ICPT) reported earnings 30 days ago. What's next for the stock?

GlobeNewsWire - 1 month ago

NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Intercept Pharmaceuticals, In...

Newsfile Corp - 1 month ago

New York, New York--(Newsfile Corp. - December 8, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Intercept Pharmaceuticals, Inc....

GlobeNewsWire - 1 month ago

NEW YORK, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) be...

Newsfile Corp - 1 month ago

New York, New York--(Newsfile Corp. - December 8, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secur...

PRNewsWire - 1 month ago

NEW YORK, Dec. 7, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) between Septemb...

GlobeNewsWire - 1 month ago

NEW YORK, Dec. 05, 2020 (GLOBE NEWSWIRE) -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securiti...

Business Wire - 1 month ago

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) between September 28, 2019 ...

About ICPT

Intercept Pharmaceuticals, a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. Its lead products candidate is the Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid in adults. The company is also developing Ocaliva for various indications, including nonalcoholic steatohepatitis (NASH); and several other product candidates in var... [Read more...]

Industry
Biotechnology
IPO Date
Oct 11, 2012
CEO
Jerome B. Durso
Employees
583
Stock Exchange
NASDAQ
Ticker Symbol
ICPT
Full Company Profile

Financial Performance

In 2019, ICPT's revenue was $252.00 million, an increase of 40.15% compared to the previous year's $179.80 million. Losses were -$344.68 million, 11.5% more than in 2018.

Financial Statements

Analyst Forecasts

According to 24 analysts, the average rating for ICPT stock is "Buy." The 12-month stock price forecast is 52.26, which is an increase of 77.39% from the latest price.

Price Target
$52.26
(77.39% upside)
Analyst Consensus: Buy